Cargando…

PIN54 Analysis of COVID-19 Treatment Drugs Availability in Ukraine

Detalles Bibliográficos
Autores principales:	Blavatska, O., Blavatskyi, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Infectious Diseases - Health Policy & Regulatory
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177563/ http://dx.doi.org/10.1016/j.jval.2021.04.1242

Ejemplares similares

PIN44 Benefit Design Considerations during Emergencies: Lessons from Covid 19
por: Panelo, C.I., et al.
Publicado: (2020)

PIN42 Current Trends in Covid-19 Testing Rates and Unmet NEEDS
por: Sethi, A., et al.
Publicado: (2020)

PIN1 Polypharmacy Among COVID-19 Patients: A Prisma-Based Systematic Review of Available Literature
por: Iloanusi, S., et al.
Publicado: (2021)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

A 54‐year‐old healthy patient with meningitis and conjunctivitis
por: Troché, Gilles, et al.
Publicado: (2021)

Cancer education in Ukraine
por: Chekhun, Vasyl F, et al.
Publicado: (2013)

Evaluation of reoperations for removal of bioabsorbable plates and screws based on adverse events reports from PMDA, Japan
por: Kobayashi, Tomoko, et al.
Publicado: (2020)

PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States
por: Chhatwal, J., et al.
Publicado: (2020)

Measles: a new danger for Ukraine’s children! The need for an effective and timely vaccination prevention campaign for an insidious disease that comes from afar
por: ORSINI, DAVIDE, et al.
Publicado: (2023)

PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients
por: Mori, T.
Publicado: (2020)

Joint effort: a call for standardization in total joint arthroplasty data reporting
por: Liebeskind, Alexander Y, et al.
Publicado: (2021)

Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis
por: Padula, W., et al.
Publicado: (2020)

The rare manifestations in tuberculous meningoencephalitis: a review of available literature
por: He, Rong li, et al.
Publicado: (2023)

Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
por: Chopra, Vineet, et al.
Publicado: (2021)

PIN33 Public Health Behaviour Changes during the Covid-19 Outbreak in China: A Comparison in Different Risk Groups
por: Miao, F., et al.
Publicado: (2020)

PIN37 Projection of Covid-19 Based on Decision Tree Analysis: WE Have NOT Won but WE Have NOT Lost the WAR!
por: Jaafar, H., et al.
Publicado: (2020)

Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial
por: Kralj-Hans, Ines, et al.
Publicado: (2023)

396 Quantitative Analysis of FDA Warning Letters Related to the Use of Social Media Sites in Product Misbranding for the Treatment, Prevention, or Diagnosis of COVID-19
por: Ajaj, Mahmoud, et al.
Publicado: (2023)

Indian regulatory update during the COVID-19 pandemic
por: Bhave, Amita Chandan
Publicado: (2020)

Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia
por: Chabot, A. Bert, et al.
Publicado: (2021)

Use of Off-Label Drugs in COVID-19: Clinicians’ Perceptions Based on a Cross-Sectional Observational Study
por: Sagar, Anubha, et al.
Publicado: (2023)

Indian Regulatory Update-2 during the COVID-19 pandemic
por: Bhave, Amita
Publicado: (2020)

PIN59 COVID-19: The Real-World Hospitalized Patient Experience
por: Rasouliyan, L., et al.
Publicado: (2021)

Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
por: Dambha-Miller, Hajira, et al.
Publicado: (2020)

Clinical use of remdesivir in COVID-19 treatment: a retrospective cohort study
por: Pham, Hong Tham, et al.
Publicado: (2023)

PIN29 Evaluation of Healthcare Workers' Knowledge, Attitude and Practices Related to Covid-19: A Multicenter CROSS-Sectional Study from Pakistan
por: Salman, M., et al.
Publicado: (2020)

COVID-19 Rebound After Paxlovid Treatment: A Case Series and Review of Literature
por: Alshanqeeti, Shatha, et al.
Publicado: (2022)

Severity Status of COVID-19 and Its Associated Factors at the Nyarugenge Treatment Center in Rwanda
por: Ntambara, James, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1m9mqnt75m395e73oqk6r59iap